London, UK, 15th June 2018 / Check4Cancer has been awarded ‘Diagnostics provider of the year’ at the 2018 Health Investor Awards held at the Grosvenor Hotel, London.

Having been nominated for three years in a row, Check4Cancer was praised by the judges for its “high quality patient-centred, medically led service with clear targets for an effective one-stop approach diagnostic pathway” and its “level of clinical audit underpinning the outcomes”.

Accepting the award Prof Gordon Wishart, Chief Medical Officer for Check4Cancer, commented “We are thrilled to have been recognised for our commitment to patient focussed, reliable early cancer detection. Our best practice diagnostic pathways for breast & skin cancer have given patients rapid access to an accurate and reliable diagnosis, reducing average times to diagnosis and improving patients’ experience. We would like to thank the Health Investor Awards for recognising that out audited pathways have increased clinical governance in the private sector.